Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer.
about
The use of proteomics to identify novel therapeutic targets for the treatment of disease.Proteomics and biomarkers in clinical trials for drug developmentProteomics and ovarian cancer: integrating proteomics information into clinical careProteomics as a guiding tool for more effective personalized therapy.Potential markers for detection and monitoring of ovarian cancer.A retrospective analysis of clinicopathological and prognostic characteristics of ovarian tumors in the State of Espírito Santo, Brazil.LC-MS(E), Multiplex MS/MS, Ion Mobility, and Label-Free Quantitation in Clinical Proteomics.
P2860
Q30361936-01422C3F-AD82-4287-80DB-148F0FCA006EQ30402667-B12E7FBA-3C36-4B8D-9331-487D2EDA3634Q34126627-37122B22-AF71-436A-9781-03FEA0595430Q34480451-43793B49-23FA-47D3-B1E8-A50864F5EC5FQ34960174-884BE8A0-D341-40A6-A7E8-A57635373B59Q35185036-858EC25B-5B39-4538-8C85-F76BBCDA3DC5Q39146398-3BE3BA29-42F5-4E45-A860-A4CD48D5953F
P2860
Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Applying proteomics in clinica ...... limitations in ovarian cancer.
@ast
Applying proteomics in clinica ...... limitations in ovarian cancer.
@en
type
label
Applying proteomics in clinica ...... limitations in ovarian cancer.
@ast
Applying proteomics in clinica ...... limitations in ovarian cancer.
@en
prefLabel
Applying proteomics in clinica ...... limitations in ovarian cancer.
@ast
Applying proteomics in clinica ...... limitations in ovarian cancer.
@en
P2093
P1476
Applying proteomics in clinica ...... limitations in ovarian cancer.
@en
P2093
Elise C Kohn
Meghan S Liel
Nana E Tchabo
P304
P356
10.2165/00129785-200505030-00001
P577
2005-01-01T00:00:00Z
P6179
1033612877